News | January 31, 2012

ACR Dose Index Registry Reaches Milestones: One Million Scans, 300 Facilities


January 31, 2012 — Since its launch less than a year ago, more than one million computed tomography (CT) scans have been contributed to the American College of Radiology (ACR) Dose Index Registry (DIR) and compiled for analysis. The DIR currently has 326 registered facilities including private practices, hospital-based facilities and academic centers.

Data collected from the DIR — which allows imaging facilities to compare their CT dose indices to regional and national values — is used to establish national benchmarks for CT dose indices to help ensure that patients receive safe, quality imaging care.  

“The tremendous interest and participation we’ve seen to date shows that medical imaging providers are committed to optimizing the radiation dose that their patients receive from CT scans. With one million scans already, we are well on our way to establishing national benchmarks. Those benchmarks will enhance our ability, and that of individual facilities, to track dose reduction efforts over time and ultimately lower the radiation dose that Americans receive from medical imaging scans,” said Richard L. Morin, Ph.D., chair of the ACR Dose Index Registry. 

The DIR is part of the overall ACR approach to medical radiation reduction, which includes mandatory accreditation of all medical imaging providers and greater adoption of computerized decision support/imaging ordering systems based on ACR Appropriateness Criteria. 

For more information: nrdr.acr.org


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now